Indications and uses
Symptomatic treatment of shingles
RANUNCULUS BULBOSUS - Aidance Skincare & Topical Solutions, LLC
- Manufacturer
- Aidance Skincare & Topical Solutions, LLC
- Effective date
- 2014-05-13
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:05:44
Label at a glance#
ProductTerrasil S.O.S. Formula Maximum Strength
Active ingredientRANUNCULUS BULBOSUS, SODIUM CHLORIDE
Label structure7 sections
Dosage and administration
Wash and dry affected skin. Apply a thin layer of Terrasil. Repeat procedure 2-3 times daily until symptoms are relieved. Store at room temperature.
Label contents#
Full prescribing information#
Active Ingredients
Natrum Muriaticum 3X HPUS, Ranunculus Bulbosus 10X HPUS
The letters HPUS indicate the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopeia of the United States
Purpose
Natrum Muriaticum - Zoster Shingle Symptom Relief
Ranunculus Bulbosus - Zoster Shingle Blisters, Stinging Pain
Uses
Symptomatic treatment of shingles
Warnings
For external use only.
Virally based infections are contagious. This product will not stop the spread of viral infections.
Do not use - in the eyes - over large areas of the body - if you are allergic to any ingredient in this product.
Ask a doctor before use if pregnant or nursing.
Stop use and ask a doctor if condition worsens or symptoms persist for more than 7 days.
Keep out of reach of children.
If swallowed, call poison control or seek medical help.
Directions
Wash and dry affected skin. Apply a thin layer of Terrasil. Repeat procedure 2-3 times daily until symptoms are relieved. Store at room temperature.
Inactive Ingredients
cera alba (organic beeswax), juniperus virginiana (cedarwood) oil, magnesium oxide, palmarosa oil, silver oxide, simmondsia chinensis (jojoba) seed oil, zinc oxide
PRINCIPAL DISPLAY PANEL - 44g Label
terrasil MAX with Activated Minerals
S.O.S. Formula
Fast. Soothing. All-Natural.
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 24909-149-14 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4fa8-f424-e053-dadaa90a57ce | Drug Facts |
| 24909-149-44 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4fa8-f424-e053-dadaa90a57ce | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24909-149-14 | Terrasil S.O.S. FormulaMaximum Strength | 14 g in 1 JAR | OINTMENT | 14 | 1 | |
| 24909-149-44 | Terrasil S.O.S. FormulaMaximum Strength | 44 g in 1 JAR | OINTMENT | 44 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 24909-149 | TERRASIL S.O.S. FORMULA MAXIMUM STRENGTH (NATRUM MURIATICUM, RANUNCULUS BULBOSUS) OINTMENT [AIDANCE SKINCARE & TOPICAL SOLUTIONS, LLC] | 1 | Legacy NDC, 2 package rows | 20140514_fdd54b01-3b95-4bbc-9316-9c7a5b333c38.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| RANUNCULUS BULBOSUS | ACTIVE INGREDIENT | AEQ8NXJ0MB | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| RANUNCULUS BULBOSUS | ACTIVE MOIETY | AEQ8NXJ0MB | 1 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| JOJOBA OIL | INACTIVE INGREDIENT | 724GKU717M | 1 | |
| JUNIPERUS VIRGINIANA OIL | INACTIVE INGREDIENT | PAD4FN7P2G | 1 | |
| MAGNESIUM OXIDE | INACTIVE INGREDIENT | 3A3U0GI71G | 1 | |
| PALMAROSA OIL | INACTIVE INGREDIENT | 0J3G3O53ST | 1 | |
| SILVER OXIDE | INACTIVE INGREDIENT | 897WUN6G6T | 1 | |
| WHITE WAX | INACTIVE INGREDIENT | 7G1J5DA97F | 1 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 1 |
Products#
Every source-derived product name is available through these pages.
- Terrasil S.O.S. Formula Maximum Strength
- Natrum Muriaticum, Ranunculus Bulbosus
- RANUNCULUS BULBOSUS
- SODIUM CHLORIDE
- SODIUM CATION
- JOJOBA OIL
- JUNIPERUS VIRGINIANA OIL
- MAGNESIUM OXIDE
- PALMAROSA OIL
- SILVER OXIDE
- WHITE WAX
- ZINC OXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 24909-149 | 24909-149-14, 24909-149-44 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| RANUNCULUS BULBOSUS | AEQ8NXJ0MB | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| JOJOBA OIL | 724GKU717M | IACT |
| JUNIPERUS VIRGINIANA OIL | PAD4FN7P2G | IACT |
| MAGNESIUM OXIDE | 3A3U0GI71G | IACT |
| PALMAROSA OIL | 0J3G3O53ST | IACT |
| SILVER OXIDE | 897WUN6G6T | IACT |
| WHITE WAX | 7G1J5DA97F | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / RESPIRATORY (INHALATION) | 3.11 %w/v | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET / SUBLINGUAL | 15 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | AEROSOL, FOAM / TOPICAL | 2 %w/w | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CAPSULE, EXTENDED RELEASE / ORAL | 71 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SUPPOSITORY / RECTAL | 375 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, DELAYED RELEASE / ORAL | 368 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, FILM COATED / ORAL | 80 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM, AUGMENTED / TOPICAL | 10 %w/w | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM / TOPICAL | 500 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE, DELAYED RELEASE / ORAL | 78 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, DELAYED RELEASE / ORAL | 0.08 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, EXTENDED RELEASE / ORAL | 25.74 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE / ORAL | 20 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / INTRAVENOUS | 3.11 %w/v | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, EXTENDED RELEASE / ORAL | 14 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET / ORAL | 5 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | OINTMENT / TOPICAL | 2100 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CAPSULE / ORAL | 79 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | OINTMENT, AUGMENTED / TOPICAL | 429 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET / ORAL | 63 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM / VAGINAL | 40 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | GUM, CHEWING / BUCCAL | 173 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, FILM COATED / ORAL | 0.2 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE, EXTENDED RELEASE / ORAL | 75 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | LOTION / TOPICAL | 1 %w/w | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | SUPPOSITORY / RECTAL | 265 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, COATED / ORAL | 3 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 18f25691-ef1b-446b-8683-093e9fb19bd9 | fdd54b01-3b95-4bbc-9316-9c7a5b333c38 | 2014-05-13 | Warnings | 18f25691-ef1b-446b-8683-093e9fb19bd9 fdd54b01-3b95-4bbc-9316-9c7a5b333c38 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.